Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors …
Background: Intravenous ketamine has been established as an efficacious and safe
treatment, with transient effect, for treatment-resistant depression. However, the …
treatment, with transient effect, for treatment-resistant depression. However, the …